首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort
【24h】

Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort

机译:解开常见的von Willebrand因子变种对冯维尔布朗疾病表型的影响:西班牙群岛冯维尔布朗疾病分子与临床剖面的探索性研究

获取原文
获取原文并翻译 | 示例
           

摘要

The clinical diagnosis of von Willebrand disease (VWD), particularly type 1, can be complex because several genetic and environmental factors affect von Willebrand factor (VWF) plasma levels. An estimated 60% of the phenotypic variation is attributable to hereditary factors, with the ABO blood group locus being the most influential. However, recent studies provide strong evidence that nonsynonymous single nucleotide variants (SNVs) contribute to VWF and factor VIII phenotypic variability in healthy individuals. This study aims to investigate the role of common VWF SNVs on VWD phenotype by analyzing data from 219 unrelated patients included in the "Molecular and Clinical Profile of von Willebrand Disease in Spain project." To that end, generalized linear mixed-effects regression models were fitted, and additive and epistatic analyses, and haplotype studies were performed, considering five VWD-related measures (bleeding score, VWF:Ag, VWF:RCo, factor VIII:C, and VWF:CB). According to these analyses, homozygotes: for p.Thr789Ala(C) would be expected to show 39% higher VWF:Ag levels; p.Thr1381Ala(C), 27% lower VWF:Ag levels; and p.Gln852Arg(C), 52% lower VWF:RCo levels. Homozygotes for both p.Thr789Ala(C) and p.Gln852Arg(T) were predicted to show 185% higher VWF:CB activity, and carriers of two copies of the p.Thr1381Ala(T)/p.Gln852Arg(T) haplotype would present a 100% increase in VWF:RCo activity. These results indicate a substantial effect of common VWF variation on VWD phenotype. Although additional studies are needed to determine the true magnitude of the effects of SNVs on VWF , these findings provide new evidence regarding the contribution of common variants to VWD, which should be taken into account to enhance the accuracy of the diagnosis and classification of this condition. ClinicalTrials.gov identifier: NCT02869074.
机译:von Willebrand疾病(VWD),特别是1型的临床诊断可能是复杂的,因为若干遗传和环境因素会影响von Willebrand因子(VWF)血浆水平。估计的60%的表型变异可归因于遗传因素,ABO血型基因座是最有影响力的。然而,最近的研究提供了强有力的证据表明非邻文单一核苷酸变体(SNV)有助于HWF和健康个体的因子VIII表型变异性。本研究旨在通过分析来自于219个无关患者的数据,探讨共同的VWF SNV在VWD表型上的作用,分析了219例无关患者中包含的“冯维尔布朗疾病的分子和临床型材”项目中的分子和临床剖面。“为此,考虑五个VWD相关措施(出血评分,VWF:AG,VWF:RCO,因子VIII:C,和术语,VWF:RCO,因子VIII:C,和vwf:cb)。根据这些分析,Homozygotes:对于P.Thrh789Ala(c)预计将显示39%的VWF:AG水平; P.Thrhr1381Ala(C),27%降低VWF:AG水平;和p.gln852arg(c),52%降低VWF:RCO水平。预计P.Thr789Ala(c)和p.Gln852ARG(T)的纯合酚,以显示185%较高的VWF:Cb活性,以及​​P.Thrl1381Ala(T)/p.GlN852ARG(T)单倍型的两份拷贝的载体提高VWF的100%增加:RCO活动。这些结果表明了常见的VWF变异对VWD表型的显着效果。虽然需要额外的研究来确定SNV对VWF对VWF的影响的真正大小,但这些发现提供了有关常见变体对VWD的贡献的新证据,这应该考虑到提高这种情况的诊断和分类的准确性。 ClinicalTrials.gov标识符:NCT02869074。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号